Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Radix Industries (India) Ltd

RADIXIND
BSE
182.50
0.14%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Radix Industries (India) Ltd

RADIXIND
BSE
182.50
0.14%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
274Cr
Close
Close Price
182.50
Industry
Industry
Personal Care
PE
Price To Earnings
80.04
PS
Price To Sales
5.49
Revenue
Revenue
50Cr
Rev Gr TTM
Revenue Growth TTM
13.60%
PAT Gr TTM
PAT Growth TTM
31.92%
Peer Comparison
How does RADIXIND stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
RADIXIND
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
971088713161281217
Growth YoY
Revenue Growth YoY%
-11.6142.7115.1-15.7-12.9-1.835.692.454.915.2-9.311.5
Expenses
ExpensesCr
86977613141171116
Operating Profit
Operating ProfitCr
111111111111
OPM
OPM%
7.69.66.213.612.011.04.89.37.810.18.38.3
Other Income
Other IncomeCr
000000000001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
111111111112
Tax
TaxCr
000000000000
PAT
PATCr
000111011111
Growth YoY
PAT Growth YoY%
20.5142.112.545.638.315.2-6.749.33.118.969.042.0
NPM
NPM%
5.26.54.68.28.27.63.16.45.57.85.98.1
EPS
EPS
0.30.30.30.50.40.40.30.70.50.40.50.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
563014121111282526334850
Growth
Revenue Growth%
137.8-46.2-54.0-13.0-11.3-1.1160.0-7.63.325.746.23.4
Expenses
ExpensesCr
4826121099252324304446
Operating Profit
Operating ProfitCr
842222222344
OPM
OPM%
14.413.016.718.219.318.78.09.69.110.17.98.5
Other Income
Other IncomeCr
000000000001
Interest Expense
Interest ExpenseCr
110000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
732222222345
Tax
TaxCr
211001011111
PAT
PATCr
521111122233
Growth
PAT Growth%
229.9-58.5-38.30.6-1.3-4.518.07.31.446.217.630.6
NPM
NPM%
8.86.89.110.511.711.35.15.95.86.85.46.9
EPS
EPS
3.31.40.80.80.60.80.91.01.01.51.82.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
101010101015151515151515
Reserves
ReservesCr
557772233467
Current Liabilities
Current LiabilitiesCr
14454761072100
Non Current Liabilities
Non Current LiabilitiesCr
000000021000
Total Liabilities
Total LiabilitiesCr
282022202423282721202123
Current Assets
Current AssetsCr
282022202423272618171820
Non Current Assets
Non Current AssetsCr
000000113333
Total Assets
Total AssetsCr
282022202423282721202123

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-610-23-12-35848
Investing Cash Flow
Investing Cash FlowCr
0000000-1-1-10
Financing Cash Flow
Financing Cash FlowCr
6-101-32-23-3-8-4-2
Net Cash Flow
Net Cash FlowCr
00000-102-206
Free Cash Flow
Free Cash FlowCr
-610-23-11-34737
CFO To PAT
CFO To PAT%
-120.1496.1-123.0253.7-113.3126.3-185.0328.1505.0186.6286.6
CFO To EBITDA
CFO To EBITDA%
-72.7257.9-66.6145.8-68.575.9-118.2202.3324.2125.0197.1

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2931227763769641121118228246
Price To Earnings
Price To Earnings
62.366.761.649.660.681.328.880.577.0102.193.5
Price To Sales
Price To Sales
5.24.05.65.27.19.11.54.84.56.95.1
Price To Book
Price To Book
20.07.94.63.74.55.72.36.66.512.011.8
EV To EBITDA
EV To EBITDA
37.431.835.329.939.751.623.052.250.568.662.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.115.122.126.128.533.112.715.417.316.413.1
OPM
OPM%
14.413.016.718.219.318.78.09.69.110.17.9
NPM
NPM%
8.86.89.110.511.711.35.15.95.86.85.4
ROCE
ROCE%
32.820.810.410.58.58.57.99.011.217.117.9
ROE
ROE%
33.513.27.57.57.47.18.18.38.411.812.6
ROA
ROA%
17.410.35.76.25.35.25.15.67.311.312.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Radix Industries (India) Limited is a prominent Indian public limited company specializing in the **manufacturing, processing, and global distribution of human hair products**. Headquartered in **Andhra Pradesh**, the company leverages India’s status as a premier source of high-quality human hair to serve a diverse international clientele across the fashion, beauty, and medical sectors. --- ### **Core Business Operations & Integrated Manufacturing** The company operates within a single reportable business segment: the processing and sale of **Human Hair**. Radix Industries manages a sophisticated, integrated value chain from its primary facility to international retail markets. * **Integrated Production Facility:** Operations are centralized at a specialized plant in **Tanuku, West Godavari District, Andhra Pradesh**. This location provides strategic access to raw material sourcing and logistical infrastructure. * **Product Specialization:** The portfolio is centered on **human hair wigs and extensions**. Unlike synthetic alternatives, these products are prized for their **authentic appearance**, durability, and ability to be **heat-styled and colored**. * **Global Export Footprint:** The company is an export-oriented entity, with a strategic focus on high-demand regions including **North America, Europe, and Sub-Saharan Africa**. Key specific markets include **China, Brazil, Spain, South Korea, and the United Kingdom**. * **Risk Mitigation:** To manage the volatility of international trade, the company actively utilizes **forward contracts** to hedge against **foreign exchange risk** associated with export receivables. --- ### **Strategic Product Portfolio & Market Positioning** Radix Industries aligns its output with two primary consumer pillars: aesthetic enhancement and medical necessity. #### **1. Hair Wigs and Extensions** * **Human Hair Dominance:** This remains the primary growth driver. The company positions these as **sustainable and eco-friendly** alternatives to "fast fashion" synthetic fibers. * **Medical Applications:** Products are engineered for consumers experiencing **alopecia, pattern baldness, chemotherapy-induced hair loss, and postpartum shedding**. * **Fashion & Aesthetics:** Catering to the "celebrity-driven" trend, the company provides volume-enhancing extensions and full-coverage wigs for the global beauty market. #### **2. Organic and Natural Hair Care Expansion** The company has diversified into the **clean-label** personal care space to complement its hardware (wigs) with software (topical care). * **Clean-Label Formulations:** Focus on **vegan and chemical-free** shampoos, conditioners, and colorants. * **Strategic Brand Synergy:** Through the **AVA Group**, the flagship brand **Medimix** launched the **Total Care Shampoo** in **May 2022**, targeting all hair types with natural ingredients. * **R&D Investment:** Continuous capital allocation toward **Research and Development** ensures the company stays ahead of the shift toward **organic/natural** personal care. --- ### **Financial Performance & Shareholder Value** Radix Industries has demonstrated a robust upward trajectory in both revenue and profitability, supported by disciplined corporate actions. | Financial Metric (₹ in Lacs) | FY 2023-24 (Audited) | FY 2022-23 (Audited) | Growth (%) | | :--- | :---: | :---: | :---: | | **Total Revenue** | **3,313.17** | **2,626.92** | **+26.12%** | | **Net Profit After Tax (PAT)** | **223.48** | **152.87** | **+46.19%** | | **Dividend Per Share** | **-** | **₹1.00 (10%)** | **N/A** | * **Recent Dividend:** For the fiscal year ended **March 31, 2025**, the Board recommended a dividend of **₹0.50 per equity share** (**5% payout** on a **Face Value of ₹10**). * **Capital Structure:** As of **March 31, 2025**, **99.96%** of the paid-up share capital is held in **dematerialized form** (**ISIN: INE576N01014**). * **Instruments:** The company has issued **zero** GDRs, ADRs, or convertible warrants, maintaining a clean equity structure. --- ### **Global Market Dynamics & Growth Strategy** The global hair wigs and extensions market was valued at **USD 7.5 billion in 2024** and is projected to reach between **USD 12.6 billion and USD 15.5 billion by 2034**, with some long-term estimates reaching **USD 30.7 billion by 2032**. **Strategic Growth Pillars:** * **U.S. Market Penetration:** The company has approved the incorporation of a **Wholly Owned Subsidiary (WOS) in the United States** to establish a direct-to-market presence in the world’s largest consuming region. * **Digital Transformation:** Integration of **e-commerce** platforms and **AI-powered virtual try-on tools** to enhance the consumer purchasing journey. * **Sector CAGR:** Radix is positioned to capture a significant share of the industry's projected **8% to 10.2% CAGR**. --- ### **Leadership & Governance Framework** The company is guided by a board with deep industrial and marketing expertise, recently reinforced by new appointments to ensure regulatory excellence. | Name | Position | Tenure/Status | | :--- | :--- | :--- | | **Sri. G. Raghu Rama Raju** | Chairman & Managing Director | Re-appointed until **Aug 2026** | | **Sri. G.G.R. Prabhakara Raju** | Director & CFO | Key Financial Oversight | | **Sri. Rama Krishna Chilukuri** | Independent Director | Appointed **Aug 2025** | | **Sri. K.S. Gaurav Tummala** | Company Secretary | Appointed **Aug 2025** | | **M/s. Brahmayya and Co** | Statutory Auditors | 5-Year Term | | **M/s. P S Rao & Associates** | Secretarial Auditor | Recommended for 5-Year Term | --- ### **Risk Profile & Mitigation Factors** Investors should consider the following operational and macroeconomic headwinds: * **Capital Intensity:** Raw hair cannot be sourced "just-in-time." This necessitates **bulk purchasing** and maintains high **inventory levels**, tying up significant **working capital**. * **Medical Competition:** The rise of permanent solutions, such as **hair transplants** and pharmaceutical treatments (**Minoxidil, Finasteride**), competes with the wig segment. * **Market Fragmentation:** The company faces stiff competition from the **unorganized sector** in India and other Asian processing hubs. * **Macroeconomic Sensitivity:** Exposure to **sticky core inflation** and global **monetary policy tightening** may impact discretionary spending in Western markets. * **Supply Chain Vulnerability:** Dependency on overseas markets makes the company sensitive to geopolitical shifts and international shipping costs. ### **Investment Summary** Radix Industries (India) Limited offers a specialized play on the global beauty and medical aesthetics market. With a **46% YoY profit growth** in the last audited cycle, a clear **U.S. expansion strategy**, and a transition toward **clean-label hair care**, the company is evolving from a traditional processor into a diversified global hair solutions provider.